FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

G & W Laboratories Indocin Recall

Indocin (Indomethacin) suppositories, USP, 50 mg, laminate strips packed in boxes of 30…

G & W Laboratories, Inc. · South Plainfield, NJ

Risk level
Class II
Reported by FDA
Mar 8, 2017
Recall ID
D-0501-2017
Check your lot numberHow we source this data

Summary

G & W Laboratories recalled Indocin starting Feb 7, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0501-2017 on Mar 8, 2017. Reason: Failed Impurities/Degradation Specifications: Out of specification (OOS) for total impurity and out of trend for known impurity results encountered during stability testing. Status: Terminated.

Why it was recalled

Failed Impurities/Degradation Specifications: Out of specification (OOS) for total impurity and out of trend for known impurity results encountered during stability testing.

Product description

Indocin (Indomethacin) suppositories, USP, 50 mg, laminate strips packed in boxes of 30, Rx only, Manufactured by: G&W Laboratories Inc. South Plainfield, NJ 07080, Distributed by Iroko Pharmaceuticals, LLC Philadelphia, PA 19112, NDC 42211-0102-43

Lot numbers, UPCs & expiration codes

Lot #: 017600011, Exp. Jan 2018, 0176000014, Exp. Aug 2018, 017600015, Exp. Sep 2018

Where it was sold

Within United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0501-2017
Classification
Class II
Status
Terminated
Recall initiated
Feb 7, 2017
FDA report date
Mar 8, 2017
Quantity
3456 boxes
Recall type
Voluntary: Firm initiated
Recalling firm
G & W Laboratories, Inc.

Original FDA data

Every field from FDA enforcement report D-0501-2017, exactly as published.

Show all FDA fields
City
South Plainfield
State
NJ
Status
Terminated
Country
United States
Event ID
76430
Address
111 Coolidge St
Code information
Lot #: 017600011, Exp. Jan 2018, 0176000014, Exp. Aug 2018, 017600015, Exp. Sep 2018
Postal code
07080-3895
Report date
Mar 8, 2017
Product type
Drugs
Recall number
D-0501-2017
Classification
Class II
Recalling firm
G & W Laboratories, Inc.
Product quantity
3456 boxes
Termination date
Jun 18, 2018
Reason for recall
Failed Impurities/Degradation Specifications: Out of specification (OOS) for total impurity and out of trend for known impurity results encountered during stability testing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Indocin (Indomethacin) suppositories, USP, 50 mg, laminate strips packed in boxes of 30, Rx only, Manufactured by: G&W Laboratories Inc. South Plainfield, NJ 07080, Distributed by Iroko Pharmaceuticals, LLC Philadelphia, PA 19112, NDC 42211-0102-43
Distribution pattern
Within United States
Recall initiation date
Feb 7, 2017
Initial firm notification
Letter
Center classification date
Mar 1, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0501-2017, published Mar 8, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls